Venetoclax with high-dose methotrexate and rituximab seem effective and well-tolerated in the treatment of central nervous system involvement of chronic lymphocytic leukemia: A case report.

Beziat, Guillaume; Gauthier, Martin; Protin, Caroline; Oberic, Lucie; Lerebours, Fleur; Carlier, Jasmine; Ysebaert, Loïc

Beziat, Guillaume; Gauthier, Martin; Protin, Caroline; Oberic, Lucie; Lerebours, Fleur; Carlier, Jasmine; Ysebaert, Loïc.

Afiliação

Beziat G; Department of Hematology Institut Universitaire du Cancer de Toulouse-Oncopole Toulouse France.
Gauthier M; Department of Hematology Institut Universitaire du Cancer de Toulouse-Oncopole Toulouse France.
Protin C; Department of Hematology Institut Universitaire du Cancer de Toulouse-Oncopole Toulouse France.
Oberic L; Department of Hematology Institut Universitaire du Cancer de Toulouse-Oncopole Toulouse France.
Lerebours F; Department of Neurology CHU Purpan Toulouse France.
Carlier J; Department of Neurology CHU Purpan Toulouse France.
Ysebaert L; Department of Hematology Institut Universitaire du Cancer de Toulouse-Oncopole Toulouse France.

Clin Case Rep ; 8(2): 269-273, 2020 Feb.

Article em En | MEDLINE | ID: mdl-32128171